Sangamo Therapeutics (SGMO) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.14
-0.09
-0.05
-0

Details

Expected EPS
-0.00045
Actual EPS
-0.11
Surprise EPS
-0.11
Surprise Percent
+24,344.44%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.11 per share for Q4 2025.

0 Comments

Share your thoughts